HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&U/Monsanto

This article was originally published in The Rose Sheet

Executive Summary

Shareholders will vote on the proposed merger between Monsanto and Pharmacia & Upjohn at a meeting March 23. The new company will be called Pharmacia Corp. and will be headed by P&U President Fred Hassan. The waiting period under Hart-Scott-Rodino expired Feb. 18, indicating the Federal Trade Commission did not find any antitrust concerns regarding the merger. The companies also have filed for antitrust review in Europe. P&U and Monsanto anticipate closing the deal in the first half of the year

Latest Headlines
See All
UsernamePublicRestriction

Register

RS007706

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel